SPONSOR
Shanghai Zhongshan Hospital
Total Trials
14
Recruiting
14
Phases
Phase 2, EARLY_Phase 1, Phase 4
Conditions studied: Pituitary TumorProgressionPatients in ICUDelirium in the Intensive Care UnitFamilyPeripheral Arterial DiseasePancreatic CancerARDS (Moderate or Severe)ARDS (Acute Respiratory Distress Syndrome)Coronary Artery Disease
Shanghai Zhongshan Hospital is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Pituitary Tumor, Progression, Patients in ICU, Delirium in the Intensive Care Unit.
The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Zhongshan Hospital
How many clinical trials has Shanghai Zhongshan Hospital sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by Shanghai Zhongshan Hospital, of which 14 are actively recruiting participants. These trials cover conditions including Pituitary Tumor, Progression, Patients in ICU. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Zhongshan Hospital research focus on?
Shanghai Zhongshan Hospital clinical trials span Pituitary Tumor, Progression, Patients in ICU, Delirium in the Intensive Care Unit, Family, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Zhongshan Hospital clinical trial?
To participate in a Shanghai Zhongshan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Zhongshan Hospital trials with current recruitment status updated daily.
Clinical Trials by Shanghai Zhongshan Hospital
NCT06705036
Recruiting
Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions
Pituitary Tumor
NCT04905056 Phase 2
Recruiting
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
Progression
NCT07694687
Recruiting
A Prospective Observational Study Using the FAM-CAM
Patients in ICU
NCT05391815
Recruiting
This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.
Peripheral Arterial Disease
NCT06938282 Phase 2
Recruiting
An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
Pancreatic Cancer
NCT07558538 EARLY_Phase 1
Recruiting
A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
ARDS (Moderate or Severe)
NCT07116083
Recruiting
µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
Coronary Artery Disease
NCT05102448 Phase 4
Recruiting
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
Takayasu Arteritis
NCT07054086
Recruiting
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Esophageal Cancer
NCT07007078 EARLY_Phase 1
Recruiting
Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
Acne Vulgaris
NCT06203652
Recruiting
The Pathogenesis and Prognostic Factors of Lymphoma
Lymphoma
NCT07815119
Recruiting
TEE-Guided Versus CCTA-Guided Preprocedural Imaging for Left Atrial Appendage Closure
Nonvalvular Atrial Fibrillation
NCT07145463
Recruiting
Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
Aortic Valve Stenosis
NCT06304779
Recruiting
The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI
Postoperative Pulmonary Complications
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology